Navigation Links
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
Date:3/4/2008

cell-mediated immune responses, particularly induction of cytotoxic T lymphocytes (CTL). Immunological responses elicited by the lipid-DNA complexes have been successfully demonstrated in both prophylactic and therapeutic settings in a variety of mammals including rodents, rabbits, cats, dogs and non-human primates. This platform provides the opportunity to develop many disease-specific immunotherapy products, for which there are significant unmet medical needs.

The Company recently completed a Series A financing with Kleiner Perkins Caufield & Byers as the sole investor. It plans to start up to four clinical studies in 2008. The first will be a prophylactic vaccine for Influenza A, the second for chronic Hepatitis C, the third for Acute Myelogenous Leukemia (AML), and a fourth therapy for chronic Hepatitis B. The Company encourages partnering inquiries and can be reached at its website at http://www.juvaris.com.

About Bayer HealthCare

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading innovative companies in the health care and medical products industry. The company combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. The company's pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide.

With sales of EUR 956 million (2007) the Animal Health Division is one of the world's leading manufacturers of veterinary drugs. The division manufactures and markets approximately 100 different veterinary drugs and care products for food-supplying animals and companion animals.

Company Contact:

Martin D. Cleary

Juvaris BioTherapeutics, Inc.

925.399.6200

mdcleary@juvaris.com


'/>"/>
SOURCE Juvaris BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
2. Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
3. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
4. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools
5. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools
6. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Northern New Jersey Elementary and Middle Schools
7. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools
8. AUDIO from Medialink and Bayer: Use Caution When Choosing Your Cold Medicine
9. Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products
10. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
11. Bayer Awards Making Science Make Sense Grant to Girl Scouts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... and Wellesley, MA (PRWEB) , ... July 07, ... ... National Institute of Whole Health (NIWH) have jointly announced a partnership focused ... addressing unsolved, chronic medical case studies. The study will be conducted with NIWH ...
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in the ... website, the Invokana Ketoacidosis Lawsuit Center . The website provides information on ... for persons wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... patient advocate, will be recognized by the White House as a “Champion of ... newly-launched President’s Precision Medicine Initiative, the Champions of Change program recognizes Gleason and ...
(Date:7/6/2015)... UK (PRWEB) , ... July 07, 2015 , ... ... in the in vitro universe. Increasing incidence of AIDS, advances in the molecular ... key growth driving forces. Recent advances in detection technologies and genetic engineering also ...
(Date:7/6/2015)... ... ... “ TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... visualize what rooms will look like before they even start renovating.. , Whether a ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2
... higher levels of vitamin D in their blood may be ... study. ,The study only finds an inverse correlation ... does not mean vitamin D definitely helps prevent gum disease. ... Goldman School of Dental Medicine analyzed data from a U.S. ...
... of Pittsburgh have successfully treated heart failure in an animal ... dystrophy. The article detailing this study is published in the ... that this is the first time that a gene therapy ... author, Xiao Xiao, Ph.D., associate professor of orthopedic surgery at ...
... collaborative work Scientists now been able to map the most ... the face of future medicine. ,The study called 'HapMap' ... chart genetic differences between 269 individuals that originate from ... and Western Europe. The study involved more than 200 ...
... avoided by patients with high cholesterol especially in diabetics, ... a egg variety that does no harm to diabetics. ... especially in Indian sub-continent. 'The modified egg is a ... professor in the university's Department of Zoology to IANS., ...
... leaves of the evergreen plant Camellia sinensis . The ... known as catechins. Catechins of green tea leaves account ... (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG) and ... the total amounts of catechins in green tea. , ...
... against multiple myeloma (MM), relapse is invariably the ... a novel first-class agent that inhibits the proteasome, ... entails several molecular mechanisms, including, in particular, the ... in combination with dexamethasone and doxorubicin, is under ...
Cached Medicine News:Health News:Gene Therapy Overcomes Heart Failure In Muscular Dystrophy 2Health News:Catechins in green tea show antiviral effect on influenza virus 2Health News:Bortezomib for salvage therapy against progressive myeloma 2
(Date:7/7/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ... protection systems ("EPS"), today announced that its MGuard ... MicroNet ™ has received the Frost & ... Award.  Through active market research efforts, Frost & ... the successful introduction of new and innovative products, ...
(Date:7/7/2015)... 2015   Bionik Laboratories Corp. (OTCBB: ... a core focus in robotic exoskeleton technology for ... announced today that it has completed an additional ... of its common stock and warrants for aggregate ... private placement transaction.  This equity financing is the ...
(Date:7/7/2015)... 2015  Essentialis, a venture-backed company focused on the development ... orphan neurobehavioral and metabolic diseases, today announced that Dr. ... corporate update at the Cantor Fitzgerald Inaugural Healthcare Conference. ... Wednesday, July 8, 2015 Time: 8:00 AM Eastern Time Location: ... Essentialis, Inc. Essentialis is a ...
Breaking Medicine Technology:InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... Quest Diagnostics Incorporated (NYSE: DGX ), the ... announced today the successful completion of its acquisition of ... means of a short-form merger under Delaware law, under ... merged with and into Celera, with Celera surviving the ...
... May 17, 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Tuesday, May 24, 2011 at 9:00 a.m. PT/12:00 p.m. ET ... the Annual Meeting, Daniel M. Bradbury, president and chief executive ... To access the webcast, please log on to the ...
Cached Medicine Technology:Quest Diagnostics Successfully Completes Acquisition of Celera 2
Facial Wrap...
Very compressive support for submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Four way compression with simple contact closure...
Medicine Products: